The Organizers would like to express their sincere gratitude to the Industry Partners who continue to support the Conference.

Their unrestricted support is essential to the dissemination of the Scientific and Industry programs to the worldwide community engaged in the study and treatment oflymphoid neoplasms:

 

AbbVie

Acrotech Biopharma, Inc.

AstraZeneca

BeiGene

Bristol Myers Squibb

CRISPR Therapeutics

Eli Lilly and Company

EUSA Pharma (UK) Ltd.

Genexpath

Genmab

Incyte

Janssen

Kite, A Gilead Company

Gilead and Kite Oncology

Kyowa Kirin

Miltenyi Biomedicine

MSD

Novartis

Pierre Fabre

Regeneron

Roche

Sobi

Takeda

Viracta

 

Thank you also to the following Partners for their precious support, essential to the organization of our Conference and to the achievement of its objectives:

 

Agenzia Turistica Ticinese SA

American Association for Cancer Research – AACR

City of Lugano

European Society for Medical Oncology – ESMO

European School of Oncology – ESO

Follicular Lymphoma Foundation – FLF

IBSA Foundation for Scientific Research

International Extranodal Lymphoma Study Group - IELSG

International Lymphoma Radiation Oncology Group – ILROG

Lugano Region

Saudi Society of Blood & Marrow Transplantation - SS-BMT

Swiss Cancer League

Swiss Cancer Research foundation

Union of Chinese lymphoma Investigators – UCLI

Università della Svizzera Italiana – USI